Date of Patent: Nov. 22, 2016 Applicants:
Taisho Pharmaceutical Co., Ltd. , Toshima-ku, Tokyo, JP ;
Toyama Chemical Co., Ltd. , Shinjuku-ku, Tokyo, JP ;
Inventors:
Hajime Takashima , Toshima-ku, JP ;
Risa Tsuruta , Toshima-ku, JP ;
Tetsuya Yabuuchi , Toshima-ku, JP ;
Yusuke Oka , Toshima-ku, JP ;
Hiroki Urabe , Toshima-ku, JP ;
Yoichiro Suga , Toshima-ku, JP ;
Masato Takahashi , Toshima-ku, JP ;
Fumito Uneuchi , Toshima-ku, JP ;
Hironori Kotsubo , Toyama, JP ;
Muneo Shoji , Toyama, JP ;
Yasuko Kawaguchi , Toyama, JP ;
Int. Cl.
CPC ...
C07C 259/06 (2006.01) ; C07C 323/62 (2006.01) ; C07D 305/06 (2006.01) ; C07D 307/14 (2006.01) ; C07D 317/30 (2006.01) ; C07D 319/18 (2006.01) ; C07D 295/08 (2006.01) ; C07D 285/12 (2006.01) ; C07D 271/12 (2006.01) ; C07D 265/30 (2006.01) ; C07D 263/14 (2006.01) ; C07D 261/08 (2006.01) ; C07D 235/04 (2006.01) ; C07D 233/61 (2006.01) ; C07D 231/12 (2006.01) ; C07D 217/04 (2006.01) ; C07D 211/14 (2006.01) ; C07D 209/08 (2006.01) ; C07D 207/10 (2006.01) ; C07D 205/04 (2006.01) ; C07C 233/83 (2006.01) ; C07C 271/22 (2006.01) ; C07C 271/28 (2006.01) ; C07C 311/08 (2006.01) ; C07C 317/28 (2006.01) ; C07C 317/44 (2006.01) ; C07C 323/41 (2006.01) ; C07D 205/12 (2006.01) ; C07D 207/12 (2006.01) ; C07D 207/27 (2006.01) ; C07D 207/327 (2006.01) ; C07D 209/12 (2006.01) ; C07D 209/14 (2006.01) ; C07D 209/44 (2006.01) ; C07D 209/52 (2006.01) ; C07D 211/18 (2006.01) ; C07D 211/38 (2006.01) ; C07D 211/46 (2006.01) ; C07D 211/56 (2006.01) ; C07D 211/70 (2006.01) ; C07D 213/38 (2006.01) ; C07D 213/40 (2006.01) ; C07D 213/54 (2006.01) ; C07D 213/61 (2006.01) ; C07D 213/64 (2006.01) ; C07D 213/65 (2006.01) ; C07D 213/70 (2006.01) ; C07D 213/74 (2006.01) ; C07D 213/81 (2006.01) ; C07D 215/14 (2006.01) ; C07D 217/12 (2006.01) ; C07D 231/56 (2006.01) ; C07D 257/04 (2006.01) ; C07D 263/32 (2006.01) ; C07D 263/56 (2006.01) ; C07D 265/38 (2006.01) ; C07D 267/10 (2006.01) ; C07D 277/20 (2006.01) ; C07D 277/30 (2006.01) ; C07D 277/62 (2006.01) ; C07D 277/66 (2006.01) ; C07D 295/12 (2006.01) ; C07D 295/14 (2006.01) ; C07D 295/16 (2006.01) ; C07D 305/08 (2006.01) ; C07D 307/18 (2006.01) ; C07D 307/52 (2006.01) ; C07D 307/54 (2006.01) ; C07D 307/78 (2006.01) ; C07D 307/82 (2006.01) ; C07D 307/87 (2006.01) ; C07D 309/04 (2006.01) ; C07D 309/14 (2006.01) ; C07D 317/60 (2006.01) ; C07D 319/20 (2006.01) ; C07D 333/24 (2006.01) ; C07D 405/06 (2006.01) ; C07D 413/06 (2006.01) ; C07D 471/04 (2006.01) ; C07D 471/10 (2006.01) ; C07D 487/08 (2006.01) ; C07D 491/20 (2006.01) ; C07D 498/08 (2006.01) ; C07F 9/09 (2006.01) ; C07C 235/84 (2006.01) ; C07C 237/36 (2006.01) ; C07C 309/30 (2006.01) ; C07D 265/36 (2006.01) ; C07D 307/81 (2006.01) ; C07D 498/04 (2006.01) ; C07D 241/04 (2006.01) ; A61P 31/04 (2006.01) ;
U.S. Cl.
CPC ...
C07C 233/83 (2013.01) ; C07C 235/84 (2013.01) ; C07C 237/36 (2013.01) ; C07C 259/06 (2013.01) ; C07C 271/22 (2013.01) ; C07C 271/28 (2013.01) ; C07C 309/30 (2013.01) ; C07C 311/08 (2013.01) ; C07C 317/28 (2013.01) ; C07C 317/44 (2013.01) ; C07C 323/41 (2013.01) ; C07C 323/62 (2013.01) ; C07D 205/04 (2013.01) ; C07D 205/12 (2013.01) ; C07D 207/10 (2013.01) ; C07D 207/12 (2013.01) ; C07D 207/27 (2013.01) ; C07D 207/327 (2013.01) ; C07D 209/08 (2013.01) ; C07D 209/12 (2013.01) ; C07D 209/14 (2013.01) ; C07D 209/44 (2013.01) ; C07D 209/52 (2013.01) ; C07D 211/14 (2013.01) ; C07D 211/18 (2013.01) ; C07D 211/38 (2013.01) ; C07D 211/46 (2013.01) ; C07D 211/56 (2013.01) ; C07D 211/70 (2013.01) ; C07D 213/38 (2013.01) ; C07D 213/40 (2013.01) ; C07D 213/54 (2013.01) ; C07D 213/61 (2013.01) ; C07D 213/64 (2013.01) ; C07D 213/65 (2013.01) ; C07D 213/70 (2013.01) ; C07D 213/74 (2013.01) ; C07D 213/81 (2013.01) ; C07D 215/14 (2013.01) ; C07D 217/04 (2013.01) ; C07D 217/12 (2013.01) ; C07D 231/12 (2013.01) ; C07D 231/56 (2013.01) ; C07D 233/61 (2013.01) ; C07D 235/04 (2013.01) ; C07D 257/04 (2013.01) ; C07D 261/08 (2013.01) ; C07D 263/14 (2013.01) ; C07D 263/32 (2013.01) ; C07D 263/56 (2013.01) ; C07D 265/30 (2013.01) ; C07D 265/36 (2013.01) ; C07D 265/38 (2013.01) ; C07D 267/10 (2013.01) ; C07D 271/12 (2013.01) ; C07D 277/20 (2013.01) ; C07D 277/30 (2013.01) ; C07D 277/62 (2013.01) ; C07D 277/66 (2013.01) ; C07D 285/12 (2013.01) ; C07D 295/08 (2013.01) ; C07D 295/12 (2013.01) ; C07D 295/14 (2013.01) ; C07D 295/16 (2013.01) ; C07D 305/06 (2013.01) ; C07D 305/08 (2013.01) ; C07D 307/14 (2013.01) ; C07D 307/18 (2013.01) ; C07D 307/52 (2013.01) ; C07D 307/54 (2013.01) ; C07D 307/78 (2013.01) ; C07D 307/81 (2013.01) ; C07D 307/82 (2013.01) ; C07D 307/87 (2013.01) ; C07D 309/04 (2013.01) ; C07D 309/14 (2013.01) ; C07D 317/30 (2013.01) ; C07D 317/60 (2013.01) ; C07D 319/18 (2013.01) ; C07D 319/20 (2013.01) ; C07D 333/24 (2013.01) ; C07D 405/06 (2013.01) ; C07D 413/06 (2013.01) ; C07D 471/04 (2013.01) ; C07D 471/10 (2013.01) ; C07D 487/08 (2013.01) ; C07D 491/20 (2013.01) ; C07D 498/04 (2013.01) ; C07D 498/08 (2013.01) ; C07F 9/091 (2013.01) ; C07C 2101/02 (2013.01) ; C07C 2101/04 (2013.01) ; C07C 2101/08 (2013.01) ; C07C 2101/14 (2013.01) ; C07C 2101/16 (2013.01) ; C07C 2101/18 (2013.01) ; C07C 2102/08 (2013.01) ;
Abstract Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria includingand its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof.
Find Patent Forward Citations
Click to load US Patent References